Expedia Inc (EXPE) 112.05 $EXPE Expedia (EXPE) to List

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Expedia Inc (EXPE) 112.05 $EXPE

Expedia (EXPE) to List Its Trivago Hotel Search Platform
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:14AM CDT
Expedia Inc. (EXPE) is reportedly gearing up for an initial public offering (IPO) to list its Trivago hotel search platform.
LNKD: 192.80 (+0.07), FB: 126.51 (+0.34), STMP: 99.61 (+0.76), EXPE: 112.05 (-1.08)

Watch for Expedia to Potentially Pullback After Gaining 2.38% Yesterday
Comtex SmarTrend(R) - Thu Sep 01, 12:08PM CDT
Expedia (NASDAQ:EXPE) traded in a range yesterday that spanned from a low of $109.16 to a high of $112.18. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $111.74 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EXPE: 112.05 (-1.08)

Expedia Set to Possibly Pullback After Yesterday's Rally of 2.38%
Comtex SmarTrend(R) - Thu Sep 01, 12:07PM CDT
Expedia (NASDAQ:EXPE) traded in a range yesterday that spanned from a low of $109.16 to a high of $112.18. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $111.74 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EXPE: 112.05 (-1.08)

Watch for Shares of Expedia (EXPE) to Approach Resistance at $110.57
Comtex SmarTrend(R) - Thu Sep 01, 8:39AM CDT
Expedia (NASDAQ:EXPE) has opened bullishly above the pivot of $109.05 today and has reached the first level of resistance at $109.85. Should the shares continue to rise, the resistance pivots of $110.57 and $112.09 will be of interest.
EXPE: 112.05 (-1.08)

Expedia Partners with Red Lion, to Offer Rewards to Clients
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 10:08AM CDT
Expedia Inc. (EXPE) recently announced that it has partnered with Red Lion Hotels Corporation (RLH), to offer rewards to clients.
RLH: 6.39 (-0.01), ABTL: 16.70 (+0.30), PETS: 20.38 (+0.19), EXPE: 112.05 (-1.08)

Forcerank Expects Amazon and Priceline to Outperform Other Ecommerce Names this Week
ESTMZ - Tue Aug 23, 10:58AM CDT
Welcome to Forcerank research notes! Every week we will be giving you an inside peek at the consensus rankings for certain contests, analyzing results from past weeks, as well as reporting on any large shifts in the consensus or trends we are...
NFLX: 97.38 (unch), AMZN: 772.44 (+1.82), SPY: 218.37 (+0.98), EBAY: 32.28 (+0.15), EXPE: 112.05 (-1.08), JD: 25.55 (-0.16), CTRP: 47.90 (-1.06), GRPN: 5.36 (-0.03), MELI: 186.16 (+12.48), PCLN: 1,422.85 (+4.26), BABA: 99.25 (+1.83)

Do's, don'ts and deals for Labor Day travel: An analysis from Expedia.com
PR Newswire - Thu Aug 18, 7:01AM CDT
Today, the Expedia.com® travel analytics team announced the result of a study of booking patterns to determine the optimal options for travelers over Labor Day. It revealed that the worst day to travel for Labor Day is expected to be Friday, September 2, and the most crowded airport will likely be Hartsfield-Jackson Atlanta International Airport.
EXPE: 112.05 (-1.08)

Expedia Debuts New Expedia Labs Showcase for Developers
PR Newswire - Tue Aug 16, 8:00AM CDT
Expedia.com® today launched Expedia Labs, a new site to showcase a sampling of experimental tech and travel concepts built within Expedia or through company partnerships. Designed to give developers a dedicated platform to test and expose new travel ideas and technology, Expedia Labs also provides travelers a portal to experiment with the latest trip planning tools and applications before new features may become available on Expedia's sites and apps.
EXPE: 112.05 (-1.08)

Why is Time (TIME) Stock Popping Today?
Madeleine Johnson - Zacks Investment Research - Mon Aug 15, 12:22PM CDT
On Monday, shares of magazine publisher Time Inc. (TIME) are popping, up over 6% in late-morning trading after Jana Partners LLC, a New York-based hedge fund, announced a new, 5 million share position in the media company.
AGN: 235.96 (-1.80), TIME: 14.22 (+0.21), HTZ: 49.59 (+0.36), CSC: 49.08 (+1.45), CAG: 46.64 (+0.62), PFE: 34.77 (+0.09), EXPE: 112.05 (-1.08)

Bear of the Day: TripAdvisor (TRIP)
Eric Dutram - Zacks Investment Research - Thu Aug 11, 5:58AM CDT
Bear of the Day: TripAdvisor (TRIP)
MPX: 8.96 (+0.03), POOL: 100.42 (unch), EXPE: 112.05 (-1.08), TRIP: 61.20 (-0.12), PCLN: 1,422.85 (+4.26)

2016 Expedia Hotel Etiquette Study: America's Least Favorite Hotel Guests are Lazy Parents, Hallway Hellraisers and Loud Neighbors
PR Newswire - Tue Aug 09, 7:01AM CDT
Expedia.com® today released the results of the 2016 Expedia Hotel Etiquette Study, which asked 1,018 Americans to identify the features and amenities they prioritize when booking a hotel, as well as the guest behaviors they find most aggravating.
EXPE: 112.05 (-1.08)

World First: Pokémon Go master completes his global quest in Australia
PR Newswire - Mon Aug 08, 2:42PM CDT
Pokémon Go master Nick Johnson, the first person to catch all Pokémon available in the US, has completed his global quest to "catch 'em all" after visiting Paris, Hong Kong and Sydney.
EXPE: 112.05 (-1.08)

TripAdvisor (TRIP) Q2 Earnings & Revenues Lag, Stock Falls
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 9:16AM CDT
TripAdvisor Inc. (TRIP) reported adjusted second-quarter 2016 earnings of 28 cents per share, which missed the Zacks Consensus Estimate of 31 cents.
PETS: 20.38 (+0.19), TRIP: 61.20 (-0.12), EXPE: 112.05 (-1.08), GOOGL: 796.87 (+5.47)

Priceline Earnings Beat As Usual, Shares Up
Sejuti Banerjea - Zacks Investment Research - Fri Aug 05, 7:58AM CDT
Priceline.com (PCLN) reported second quarter results that beat the Zacks Consensus Estimate on revenue and earnings but missed on guidance.
PETS: 20.38 (+0.19), STMP: 99.61 (+0.76), EXPE: 112.05 (-1.08), EVLV: 1.91 (+0.08), GRPN: 5.36 (-0.03), PCLN: 1,422.85 (+4.26)

Watch for Shares of Expedia (EXPE) to Approach Support at $111.27
Comtex SmarTrend(R) - Thu Aug 04, 8:47AM CDT
Shares of Expedia (NASDAQ:EXPE) opened today below their pivot of $113.00 and have already reached the first level of support at $111.91. Analysts will be watching for a cross of the next downside pivot targets of $111.27 and $109.54.
EXPE: 112.05 (-1.08)

Will Priceline Suffer the Same Fate as TripAdvisor and Expedia?
ESTMZ - Thu Aug 04, 8:19AM CDT
Priceline.com Incorporated ( PCLN ) Consumer Discretionary - Internet & Catalog Retail | Reports August 4, Before Market Opens Key Takeaways The Estimize consensus is looking for earnings per share of $12.85 on $2.60 billion in revenue, 18...
SPY: 218.37 (+0.98), EXPE: 112.05 (-1.08), TRIP: 61.20 (-0.12), CTRP: 47.90 (-1.06), PCLN: 1,422.85 (+4.26)

5 Stocks to Watch After the Market Closes Today
ESTMZ - Wed Aug 03, 9:26AM CDT
TSLA : Tesla has been in the news for all the wrong reasons. In May, the company raised $1.6 billion in common stock to meet Model 3 production. This was actually a good sign that demand was outpacing supply, pushing Tesla closer profitability. It...
JACK: 101.53 (+1.83), HLF: 61.35 (+0.18), TSLA: 197.78 (-2.99), SPY: 218.37 (+0.98), CMG: 408.41 (-6.27), EXPE: 112.05 (-1.08), TRIP: 61.20 (-0.12), PCLN: 1,422.85 (+4.26), SQ: 12.05 (+0.05)

Sumptuous Sleeps: 10 amazing luxury hotels loved by you
PR Newswire - Wed Aug 03, 7:00AM CDT
Deluxe beds, designer toiletries and jaw dropping casinos are just some of the many features today's travelers expect from a luxury hotel, according to accommodation expert Hotels.com®.
EXPE: 112.05 (-1.08)

Priceline (PCLN) Stock 2Q Earnings Preview: Beat or Miss?
Sejuti Banerjea - Zacks Investment Research - Tue Aug 02, 5:34PM CDT
Priceline (PCLN) is slated to report first quarter earnings results on Aug 4 after the bell.
PETS: 20.38 (+0.19), STMP: 99.61 (+0.76), EXPE: 112.05 (-1.08), GRPN: 5.36 (-0.03), PCLN: 1,422.85 (+4.26)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Clarius Named in TIME's Top HealthTech 2026 Again

Updated Category News Views 6

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Continue Reading
Microplastics Webinar: Navigating Complex Regulations

Updated Category News Views 4

Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...

Continue Reading
Wrensilva Unveils Studio Console in White Oak

Updated Category News Views 4

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

Continue Reading
Retirement Security Faces Global Headwinds in 2026

Updated Category News Views 10

Grappling with an Uncertain Retirement Future Welcome to the 2026 Global Retirement Index (GRI), where it seems we're all being told to brace for a rough retirement ride. This year's results, crafted by Natixis Investment Managers and their pals at CoreData Research, spotlight just how shaky the ground has gotten. The core troublemakers? Aging populations, whopping public...

Continue Reading
Miguel Pantoja: Wiring a Second Chance Beyond Bars

Updated Category News Views 5

A Second Shot with Electric Dreams Miguel Pantoja, once on the rocky road of life choices, now lights up Northern California with his spark — quite literally. Walking out of federal prison, his mind was set as firmly as a bolt: first stop was a burger, second was a plan to transform his past into a new beginning. That path took him to UEI College in Sacramento, where...

Continue Reading
Unicycive's Legal Turmoil: Opportunity for Investor Action

Updated Category News Views 4

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

Continue Reading
Sequel Advisors Rebrand: Founder-Centric M&A Focus

Updated Category News Views 5

What's in a Name? A Shift to Reflect Reality When a company decides it's time to shake things up with a rebrand, they better have a good reason. Enter what's now called Sequel Advisors—shedding the old label, Transact Capital, to let founders know exactly what they’re dealing with upfront. This isn't just some slick, new logo on a letterhead. It's about aligning their...

Continue Reading
BeyondCPG Accelerator Launches Seventh Growth Program

Updated Category News Views 4

Fresh Faces in Conscious Consumerism There's nothing quite like an early morning jolt of caffeine mixed with the buzz of innovation in the air. BeyondCPG, a heavyweight in the conscious products arena, has cracked open the doors to its seventh round of powerhouse brand-boosting with the launch of its new Accelerator Track 7. They're mixing heart with hustle to give...

Continue Reading
Rise Treatment Center Launches in Vegas for Teens

Updated Category News Views 5

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Continue Reading
Dr. David Lifschutz Honored for Psychiatry Innovation

Updated Category News Views 5

Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...

Continue Reading

Top 5 Most Recently Viewed Articles

Nano Hearing Aids' CEO Global Tour: Strengthening Connections Worldwide

Updated Category News Views 58

Nano Hearing Aids' Global Strategy: A Tour to Remember Nano Hearing Aids is taking significant strides in expanding its presence worldwide. As part of this vision, Ryan F. Zackon, the esteemed CEO, is setting out on an ambitious global tour. This initiative aims to deepen partnerships and solidify relationships within the hearing aid community. Tour Objectives: Fostering...

Continue Reading
Toll Brothers Stock: A Look at 15 Years of Growth

Updated Category News Views 141

The Impressive Journey of Toll Brothers Stock Toll Brothers (NYSE: TOL) has demonstrated remarkable resilience and growth over the past 15 years. With an average annual return of 14.07%, it has outperformed the market by 1.87%. As of now, the company's market capitalization stands at an impressive $12.22 billion. Investment Potential: What If You Bought $1,000? Imagine...

Continue Reading
DigiKey Showcases Automation Innovations at SPS 2025 Event

Updated Category News Views 198

DigiKey to Showcase Automation Innovations at SPS 2025 Global distributor highlights extensive range of industrial automation products available in Europe THIEF RIVER FALLS, Minn. — DigiKey, a renowned global distributor of electronic components and automation solutions, invites attendees of the Smart Production Solutions (SPS) conference to visit its booth, #106 in...

Continue Reading
Cocrystal Pharma Advances CDI-988 in Phase 1 Clinical Trials

Updated Category News Views 120

Exciting Progress for CDI-988 in Clinical Trials Cocrystal Pharma, Inc. (NASDAQ: COCP) recently shared encouraging findings from its Phase 1 study of CDI-988, an innovative pan-viral inhibitor, during the Military Health System Research Symposium. This multi-day event focused on advancing military medical care, with Cocrystal presenting influential data that showcases the...

Continue Reading
Increased Support for Nova Minerals' Estelle Project Advancements

Updated Category News Views 153

Introduction to the Estelle Project Nova Minerals Limited (NASDAQ: NVA) has recently reported significant support for its Estelle Gold and Critical Minerals Project from Alaska State government officials and representatives from the Australian Consulate. These interactions highlight the growing recognition of the Estelle Project as crucial for the development of both...

Continue Reading